Concepedia

Kimberly Aardalen

KA

10

Publications

642

Citations

10

H-Index

2008

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis (United States)

Novartis Institutes for BioMedical Research

Kimberly Aardalen is an author at Novartis (Switzerland) specializing in medicine, tumor immunity, and tumor biology.

Top concepts

Publications per year

2008–2023

10

Publications

10

Molecular Profiling of Patient-Matched Brain and Extracranial Melanoma Metastases Implicates the PI3K Pathway as a Therapeutic Target

Guo Chen, Nitin Chakravarti, Kimberly Aardalen et al. · Clinical Cancer Research · 2014 · 209 citations · Full text

Design, Structure−Activity Relationships and in Vivo Characterization of 4-Amino-3-benzimidazol-2-ylhydroquinolin-2-ones: A Novel Class of Receptor Tyrosine Kinase Inhibitors

Paul A. Renhowe, Sabina Pecchi, Cynthia M. Shafer et al. · Journal of Medicinal Chemistry · 2008 · 134 citations · Full text

SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms

Ye Wang, Morvarid Mohseni, Angelo L. Grauel et al. · Scientific Reports · 2021 · 72 citations · Full text

Discovery of RAF265: A Potent mut-B-RAF Inhibitor for the Treatment of Metastatic Melanoma

Teresa E. Williams, Sharadha Subramanian, Joelle Verhagen et al. · ACS Medicinal Chemistry Letters · 2015 · 53 citations · Full text

, , +15

Abstract 3790: Preclinical profile of LGX818: A potent and selective RAF kinase inhibitor

Darrin D. Stuart, Nanxin Li, Daniel J. Poon et al. · Cancer Research · 2012 · 52 citations

, , +17

Rows per page

1–5 of 10